fda warning bpc-157 peptide not approved safety concerns Approval Status: Is It for Human Use? FDA's Overreach on Compounded Peptides

Our vitamin B12 booster injections are created to support your energy, mood and focus, delivered by professionals at our Soho or Westfield clinics

Using acne as a disease model, we aim to understand the molecular response of ...

Cell Tissue Res

Designed to support accurate preparation and handling in controlled scientific environments

BPC-157 - Body Protection Compound

As most undesirable effects are based on post-marketing spontaneous reporting, frequency estimation is not possible. Immune system disorders Frequency not known: Hypersensitivity reactions, such as sweating, tachycardia, and skin reactions with itching and urticaria. Gastrointestinal disorders Less frequent: Gastrointestinal complaints, such as nausea, vomiting, diarrhoea and abdominal pain. Skin and subcutaneous tissue disorders Less frequent: Cases of acne or eczema have been reported after high doses of Vitamin B12. General disorders and administration site conditions Frequency not known: Injection site reactions. Renal and urinary disorders Less frequent: Chromaturia (reddish urine, appeared during the first 8 hours after an administration and typically resolves within 48 hours).Reporting of suspected adverse reactionsReporting suspected adverse reactions after authorisation of the medicine is important. It allows continued monitoring of the benefit/risk balance of the medicine. Health care providers are asked to report any suspected adverse reactions to SAHPRA via the 6.04 Adverse Drug Reactions Reporting Form, found online under SAHPRAs publications